Generation of transgenic mice with antithetical KEL1 and KEL2 human blood group antigens on red blood cells

Transfusion

Volumn 52, Issue 12, 2012, Pages 2620-2630

  Smith, Nicole H ^a,b,c   Henry, Kate L ^a,b,c   Cadwell, Chantel M ^a,b,c   Bennett, Ashley ^a,b,c   Hendrickson, Jeanne E ^a,b,c   Frame, Tom ^a,b,c   Zimring, James C ^a,b,c  

^a Laboratory Medicine   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Immucor Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN; COMPLEMENTARY DNA; HEMOGLOBIN BETA CHAIN; KEL1 ANTIGEN; KEL2 ANTIGEN; UNCLASSIFIED DRUG;

AGAMMAGLOBULINEMIA; ALLOIMMUNIZATION; ANIMAL EXPERIMENT; ARTICLE; C57BL 6 MOUSE; CELL LABELING; CONTROLLED STUDY; DNA VECTOR; ENHANCER REGION; ERYTHROCYTE; ERYTHROCYTE LIFESPAN; ERYTHROID CELL; FLOW CYTOMETRY; HEMATOPOIESIS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; BLOOD TRANSFUSION; EPITOPES; ERYTHROCYTES; GENE LIBRARY; HUMANS; KELL BLOOD-GROUP SYSTEM; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, ANIMAL; TRANSGENES;

EID: 84870994430     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03641.x     Document Type: Article

References (23)

1. Health Care Cost and Utilization Project Facts and Figures, Statistics on hospital-based care in the United States. Most frequent all-listed procedures. 2005. [cited 2011 Dec 1]. Available from: URL: http://www.hcup-us.ahrq.gov/ reports.jsp[monograph on the internet].
2. Daniels G,. Human blood groups. 2nd ed. Oxford: Blackwell Science Ltd; 2002.
3. Reid ME, Lomas-Francis C,. The blood group antigen facts book. 2nd ed. Amsterdam: Elsevier Academic Press; 2004.
4. Hendrickson JE, Hillyer CD,. Noninfectious serious hazards of transfusion. Anesth Analg 2009; 108: 759-69.
5. Eder AF,. Update on HDFN: new information on long-standing controversies. Immunohematology 2006; 22: 188-95.
6. Heddle NM, Soutar RL, O'Hoski PL, Singer J, McBride JA, Ali MA, Kelton JG,. A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion. Br J Haematol 1995; 91: 1000-5.
7. Hoeltge GA, Domen RE, Rybicki LA, Schaffer PA,. Multiple red cell transfusions and alloimmunization. Experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993. Arch Pathol Lab Med 1995; 119: 42-5.
8. Higgins JM, Sloan SR,. Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders.[see comment]. Blood 2008; 112: 2546-53.
9. Auffray I, Marfatia S, de Jong K, Lee G, Huang CH, Paszty C, Tanner MJ, Mohandas N, Chasis JA,. Glycophorin A dimerization and band 3 interaction during erythroid membrane biogenesis: in vivo studies in human glycophorin A transgenic mice. Blood 2001; 97: 2872-8.
10. Chaudhuri A, Yuen G, Fang F, Storry J,. Development of Duffy transgenic mouse: in vivo expression of human Duffy gene with -33T->C promoter mutation in non-erythroid tissues. Br J Haematol 2004; 127: 356-9.
11. Desmarets M, Cadwell CM, Peterson KR, Neades R, Zimring JC,. Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model. Blood 2009; 114: 2315-22.
12. Hartley SB, Crosbie J, Brink R, Kantor AB, Basten A, Goodnow CC,. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 1991; 353: 765-9.
13. Westhoff CM, Reid ME,. Review: the Kell, Duffy, and Kidd blood group systems. Immunohematology 2004; 20: 37-49.
14. Tormey CA, Stack G,. Immunogenicity of blood group antigens: a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy-related antibodies. Blood 2009; 114: 4279-82.
15. Marsh WL, Redman CM,. The Kell blood group system: a review. Transfusion 1990; 30: 158-67.
16. Hendrickson JE, Desmarets M, Deshpande SS, Chadwick TE, Hillyer CD, Roback JD, Zimring JC,. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion 2006; 46: 1526-36.
17. Peterson KR, Fedosyuk H, Zelenchuk L, Nakamoto B, Yannaki E, Stamatoyannopoulos G, Ciciotte S, Peters LL, Scott LM, Papayannopoulou T,. Transgenic Cre expression mice for generation of erythroid-specific gene alterations. Genesis 2004; 39: 1-9.
18. Pu JJ, Redman CM, Visser JW, Lee S,. Onset of expression of the components of the Kell blood group complex. Transfusion 2005; 45: 969-74.
19. Oyen R, Reid ME, Rubinstein P, Ralph H,. A method to detect McLeod phenotype red blood cells. Immunohematology 1996; 12: 160-3.
20. Collec E, Colin Y, Carbonnet F, Hattab C, Bertrand O, Cartron JP, Kim CL,. Structure and expression of the mouse homologue of the XK gene. Immunogenetics 1999; 50: 16-21.
21. Chiaroni J, Dettori I, Ferrera V, Legrand D, Touinssi M, Mercier P, de Micco P, Reviron D,. HLA-DRB1 polymorphism is associated with Kell immunisation. Br J Haematol 2006; 132: 374-8.
22. Noizat-Pirenne F, Tournamille C, Bierling P, Roudot-Thoraval F, Le Pennec P-Y, Rouger P, Ansart-Pirenne H,. Relative immunogenicity of Fya and K antigens in a Caucasian population, based on HLA class II restriction analysis. Transfusion 2006; 46: 1328-33.
23. Picard C, Frassati C, Basire A, Buhler S, Galicher V, Ferrera V, Reviron D, Zappitelli JP, Bailly P, Chiaroni J,. Positive association of DRB1 04 and DRB1 15 alleles with Fya immunization in a Southern European population. Transfusion 2009; 49: 2412-7.